109146 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A. MicroRNAs, miRNAs
Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction
#2102Methods of modulating compliance of the trabecular meshwork
#2103Theranostic imaging agents and methods of use
#2104Compositions and methods for treatment of tamoxifen resistant breast cancer
#2105Nanotubes as carriers of nucleic acids into cells
#2106RNA interference suppression of neurodegenerative diseases and methods of use thereof
#2107Methods for diagnosing bone or cardiovascular disorders
#2108Methods and compositions for screening and treating developmental disorders
#2109Therapeutic compounds
#2110RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
#2111Polycomb-associated non-coding RNAs
#2112Medicament for liver regeneration and for treatment of liver failure
#2113Production and extraction of MicroRNA precursor as drug for cancer therapy
#2114Methods for regulating neural differentiation
#2115Composition for controlling chromogenesis including microRNA
#2116Citrus-greening (Huanglongbing)-induced small RNAs are potential early diagnosis markers
#2117Method of treatment of breast cancers over-expressing the SHP2 signature genes
#2118Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
#2119Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes
#2120Methods of using microRNA-26a to promote angiogenesis
#2121MicroRNAome
#2122Synthetic mimics of miR-34
#2123Compositions and methods for treating musculoskeletal diseases and disorders
#2124Aging marker, method for evaluating aging inhibitor, and cancer inhibitor
#2125Differentially expressed microRNA molecules for the treatment and diagnosis of cancer
#2126Melatonin-based treatment and diagnosis of bile duct disease
#2127Optimized miRNA constructs
#2128Compositions and methods for treatment of melanoma
#2129Recombinant virus products and methods for inhibition of expression of myotilin
#2130Methods and compositions for the diagnosis, classification, and treatment of cancer
#2131Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
#2132Oligonucleotides for modulation of target RNA activity
#2133Small RNA-dependent translational regulatory system in cell or artificial cell model
#2134Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#2135Compositions and methods for treating leukemia
#2136Direct reprogramming of cells to cardiac myocyte fate
#2137MiRNA for treating diseases and conditions associated with neo-angiogenesis
#2138Method of enhancing miR-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
#2139UCP1 (thermogenin)—inducing agents for use in the treatment of a disorder of the energy homeostasis
#2140miRNA modulators of thermogenesis
#2141Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells
#2142Treatment of angiogenesis disorders
#2143Production and utilization of a novel anti-cancer drug in therapy
#2144Supercoiled minicircle DNA for gene therapy applications
#2145Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
#2146Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer
#2147Base modified oligonucleotides
#2148MicroRNA biomarkers for human breast and lung cancer
#2149Targeting metabolic enzymes in human cancer
#2150Compositions and methods for treatment of ovarian cancer
#2151Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#2152Ultraconserved regions encoding ncRNAs
#2153Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
#2154Micro-RNA family that modulates fibrosis and uses thereof
#2155Micro-RNA family that modulates fibrosis and uses thereof
#2156MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells
#2157MicroRNAs that regulate muscle cell proliferation and differentiation
#2158Segmented micro RNA mimetics
#2159Adeno-associated virus vector for gene transfer to nervous system cells
#2160Method of deriving mature hepatocytes from human embryonic stem cells
#2161Micro-RNA family that modulates fibrosis and uses thereof
#2162CNS targeting AAV vectors and methods of use thereof
#2163Structurally designed shRNAs
#2164Nucleic acid molecules and collections thereof, their application and modification
#2165Single-stranded RNAi agents containing an internal, non-nucleic acid spacer
#2166miRNAs involved in the blood brain barrier function
#2167Methods of generating oligodendrocytes and cell populations comprising same
#2168THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#2169METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF BREAST CANCER
#2170Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
#2171Prophylactic or therapeutic agent for diabetes
#2172MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
#2173MicroRNA compositions and methods related thereto
#2174MicroRNA as a cancer progression predictor and its use for treating cancer
#2175MicroRNA-130a,b as a tumor suppressor and sensitizing agent for chemotherapy
#2176Method for modulating microRNA content in living beings and the use thereof
#2177MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT
#2178Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
#2179COMPOSITIONS AND METHODS RELATED TO MIRNA MODULATION OF NEOVASCULARIZATION OR ANGIOGENESIS
#2180MICRORNA MIRNA-31 AS A THERAPEUTIC APPROACH FOR THE TREATMENT OF CANCER
#2181Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155
#2182Mutator activity induced by microRNA-155 () links inflammation and cancer
#2183MicroRNA Signatures Predicting Responsiveness To Anti-HER2 Therapy
#2184METHODS AND COMPOSITIONS FOR INFLUENCING TUMORS USING MICRORNA-185 AS A TUMOR SUPPRESSOR
#2185Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
#2186COMPOSITIONS AND METHODS FOR PROMOTING FATTY ACID PRODUCTION IN PLANTS
#2187Cationic lipids for oligonucleotide delivery
#2188Treatment of fibrosis using microRNA 19b
#2189SUMO as a marker of cancer development and target for cancer therapy
#2190MATERIALS AND METHODS FOR PROFILING MICRORNAS
#2191Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2192Isoform of bruton's tyrosine kinase (BTK) protein
#2193ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#2194NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#2195miR-150 for the treatment of blood disorders
#2196MicroRNA induction of pluripotential stem cells and uses thereof
#2197MARKER FOR DETECTING MYOGENIC DISEASE AND DETECTION METHOD USING THE SAME
#2198MODULATING XRN1
#2199Nucleic acids for targeting multiple regions of the HCV genome
#2200Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration
#2201Nucleic Acids and Libraries
#2202Nucleic Acids and Libraries
#2203METHOD FOR PREVENTING OR TREATING MEMORY IMPAIRMENT AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREFORE
#2204Methods and compositions to modulate antiviral and immune activity responses
#2205Methods and compositions for anti-EGFR treatment
#2206miRNA compounds for treatment of prostate carcinoma
#2207MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#2208RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#2209Method for selectively inhibiting the activity of ACAT1 in the treatment of alzheimer's disease
#2210MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF
#2211METHOD FOR PROLIFERATING CARDIOMYOCYTES USING MICRO-RNA
#2212MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY
#2213TRANSGENIC PLANT MALE STERILITY
#2214Methods and compositions for reducing viral genome amounts in a target cell
#2215Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial Inflammation
#2216Compositions and methods for diagnosing and treating melanoma
#2217Method of identifying myelodysplastic syndromes
#2218SENESCENCE MARKER, METHOD FOR EVALUATING SENESCENCE INHIBITOR, AND CANCER INHIBITOR
#2219Use of miR-30e to treat vascular lesions
#2220Supercoiled minivectors for gene therapy applications
#2221Methods for identifying drug effects on a cell by determining changes in the cell's spliced message profile
#2222Th1-associated microRNAs and their use for tumor immunotherapy
#2223AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL
#2224Targeting microRNAs for the treatment of liver cancer
#2225Synthetic mimics of miR-34
#2226Reduction of off-target RNA interference toxicity
#2227Method of inhibiting miR-33 using a modified oligonucleotide
#2228MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CLL) and Uses Thereof
#2229Sirna compounds comprising terminal substitutions
#2230FUNCTIONS AND TARGETS OF LET-7 MICRO RNAS
#2231COMPOSITIONS AND METHODS RELATED TO MIRNA IN DIABETIC CONDITIONS
#2232MicroRNA-10 antagonists and MicroRNA-10 targets for use in the treatment of a glioma
#2233MicroRNA Mediated Neuronal Cell Induction
#2234Synthetic mimics of MIR-124
#2235Antiangiogenic Agent and Method for Inhibition of Angiogenesis
#2236Alternative export pathways for vector expressed RNA interference
#2237MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
#2238RNAi-mediated inhibition of histamine receptor H1-related conditions
#2239MEDICAMENT FOR THE TREATMENT AND PREVENTION OF LIVER FAILURE
#2240CMV gene products promote cancer stem cell growth
#2241MicroRNA affinity assay and uses thereof
#2242MicroRNA as a cancer progression predictor and its use for treating cancer
#2243Method of regulating gene expression
#2244NOVEL CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR OLIGONUCLEOTIDE DELIVERY
#2245Therapeutic agent for tumor
#2246Trans-acting RNA switches
#2247Method of therapy and diagnosis of atherosclerosis
#2248INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION
#2249Compositions and methods for prognosis and treatment of prostate cancer
#2250Treatment of vasculoproliferative conditions with Lrg1 anatgonists
#2251Enhancement of placental stem cell potency using modulatory RNA molecules
#2252Viral and viral associated mirnas and uses thereof
#2253Use of two microRNA moleculars in lung cancer prognosis and medicine preparation
#2254MicroRNA Signatures Differentiating Uterine and Ovarian Papillary Serous Tumors
#2255Methods for Diagnosing Stomach Cancer Using MicroRNA Signatures
#2256Methods for Diagnosing Prostate Cancer Using MicroRNA Signatures
#2257Methods for diagnosing lung cancer using MicroRNA signatures
#2258Methods for diagnosing colon cancer using MicroRNA signatures
#2259Methods for Diagnosing Breast Cancer Using MicroRNA Signatures
#2260Methods for diagnosing stomach cancer using MicroRNAs
#2261Methods for diagnosing prostate cancer using MicroRNAs
#2262Methods for diagnosing pancreatic cancer using MicroRNAs
#2263Methods for diagnosing lung cancer using microRNAs
#2264Methods for diagnosing colon cancer using MicroRNAs
#2265Methods for diagnosing breast cancer using MicroRNAs
#2266Methods for diagnosing pancreatic cancer using miR-103-1, miR-103-2, miR-24-2 and miR-107
#2267Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145
#2268Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223
#2269Methods for Diagnosing Breast and Lung Cancer Using miR-210 and miR-213
#2270Methods for diagnosing breast, colon, lung, pancreatic and prostate cancer using miR-21 and miR-17-5p
#2271Method and compounds for generation of iPSCs
#2272System for Synergistic Expression of Multiple Small Functional RNA Elements
#2273Treatment of inflammatory diseases using miR-124
#2274CELL IMAGING METHOD FOR VIEWING MICRORNA BIOGENESIS IN THE CELLS
#2275Therapeutic and diagnostic molecules
#2276Methods and products for expression of micro RNAs
#2277MIRNA INHIBITION OF SIX1 EXPRESSION
#2278TREATMENT OF PATIENTS AFTER STENT IMPLANTATION OR BALLOON DILATATION AND DRUG ELUTING STENTS
#2279COMBINATORIAL ENGINEERING
#2280Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2281Short RNA mimetics
#2282Use of MicroRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells
#2283MicroRNA-24
#2284Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#2285Compositions and methods for treatment, diagnosis and prognosis of mesothelioma
#2286Method for the preparation of micro-RNA and its therapeutic application
#2287Chemical modification of short small hairpin RNAs for inhibition of gene expression
#2288Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#2289REPROGRAMMING CANCER CELLS
#2290Method and system for monitoring nutritional uptake as a function of microflora intestinal gas levels
#2291CHEMICAL MODIFICATIONS MOTIFS FOR MIRNA INHIBITORS AND MIMETICS
#2292Live attenuated influenza virus vaccines comprising microRNA response elements
#2293Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
#2294Diagnosis and treatment of adrenocortical tumors using human microRNA-483
#2295Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#2296Amine-Containing Transfection Reagents and methods for making and using same
#2297Embryonic stem cell specific microRNAs promote induced pluripotency
#2298Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
#2299RNA targeting in alpha-synucleinopathies
#2300Gene vector
#2301Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#2302METHODS AND KITS TO GENERATE miRNA- AND SMALL RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES
#2303Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease
#2304Means And Methods For Counteracting, Preventing And/Or Determining Heart Failure, Or A Risk Of Heart Failure
#2305MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER
#2306Micro-RNA mediated modulation of colony stimulating factors
#2307Anti-MicroRNA oligonucleotide molecules
#2308COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
#2309Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification
#2310Modifications for Antisense Compounds
#2311Use of microrna-199b-5p in medical and diagnostic field
#2312MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA
#2313Use of interfering rna for treating an hiv infection
#2314MicroRNAs and uses thereof
#2315Methods of modulating smooth muscle cell proliferation and differentiation
#2316Head-and-neck tumor proliferation inhibitor
#2317Anti viral therapy
#2318METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#2319Method of diagnosing poor survival prognosis colon cancer using miR-29a
#2320Method of diagnosing poor survival prognosis colon cancer using miR-103-2
#2321MicroRNA and methods for inhibiting same
#2322Vector
#2323Combination anti-HIV vectors, targeting vectors, and methods of use
#2324Micro-RNA associated with rheumatoid arthritis
#2325METHODS AND COMPOSITIONS FOR TREATING CANCER
#2326MIR-21 promoter driven targeted cancer therapy
#2327Methods and compositions involving miRNA and miRNA inhibitor molecules
#2328Regulation of hematopoietic stem cell functions through microRNAs
#2329Phosphodiesterase 4D7 as prostate cancer marker
#2330Methods for regulating neural differentiation
#2331METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21
#2332Method of diagnosing poor survival prognosis colon cancer using miR-106a
#2333DIFFERENTIATION THERAPY FOR SARCOMAS
#2334Therapeutic and diagnostic strategies
#2335Method of diagnosing poor survival prognosis colon cancer using miR-10a
#2336Method of diagnosing poor survival prognosis colon cancer using miR-203
#2337Method of diagnosing poor survival prognosis colon cancer using miR-16b
#2338Method of diagnosing poor survival prognosis colon cancer using let-7g
#2339Method of diagnosing poor survival prognosis colon cancer using miR-181b
#2340Method for diagnosing acute lymphomic leukemia (ALL) using miR-125b
#2341Reengineering mRNA primary structure for enhanced protein production
#2342Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
#2343COMPOSITIONS AND METHODS FOR MICRO-RNA EXPRESSION PROFILING OF CANCER STEM CELLS
#2344Method for diagnosing acute lymphomic leukemia (ALL) using miR-146a
#2345Method for diagnosing acute lymphomic leukemia (ALL) using miR-222
#2346Method for diagnosing acute lymphomic leukemia (ALL) using miR-221
#2347Compositions and Methods to Treat Muscular & Cardiovascular Disorders
#2348COMPOSITIONS AND METHODS RELATING TO miR-31
#2349PROTEIN TARGETS IN DISEASE
#2350miRNA TARGETS
#2351Method for inhibiting the activity of mir-155
#2352Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
#2353Chemical modifications of monomers and oligonucleotides with cycloaddition
#2354Methods and kits for miRNA isolation and quantitation
#2355MicroRNAs in Never-Smokers and Related Materials and Methods
#2356Method of regulating NFATc2 activity in lymphocytes
#2357Structurally designed shRNAs
#2358MHC-less cells
#2359METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#2360METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#2361Oligomeric compounds and methods
#2362Compositions and methods for treating hepatic neoplasia
#2363DIAGNOSIS, PROGNOSIS AND TREATMENT OF GLIOBLASTOMA MULTIFORME
#2364Recombinant DNA constructs encoding ribonuclease cleavage blockers and methods for modulating expression of a target gene
#2365USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#2366MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
#2367Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1
#2368Compositions and methods for micro-RNA expression profiling of colorectal cancer
#2369METHOD FOR MIR-125A IN PROMOTING HEMATOPOIETIC STEM CELL SELF RENEWAL AND EXPANSION
#2370MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
#2371Micro-RNAs as Markers for Tumor Progression
#2372RNAi-mediated inhibition of histamine receptor H1-related conditions
#2373Methods of modulating mesenchymal stem cell differentiation
#2374MODULATING IMMUNE SYSTEM DEVELOPMENT AND FUNCTION THROUGH MICRORNA MIR-146
#2375RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis
#2376Transferrin/transferrin receptor-mediated siRNA delivery
#2377Compositions and methods for inhibition of nucleic acids function
#2378Targeting MicroRNAs For The Treatment Of Liver Cancer
#2379RNA interference suppression of neurodegenerative diseases and methods of use thereof
#2380Microrna compositions and methods for the treatment of myelogenous leukemia
#2381Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#2382Use of RNAi technology to inhibit ASIC3
#2383Compositions for protection and cellular delivery of interfering RNA
#2384GENE SILENCING
#2385PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2
#2386Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#2387Polynucleotides for use in treating and diagnosing cancers
#2388MicroRNAs and Uses Thereof
#2389Block copolymers and uses thereof
#2390Gene vector for inducing transgene-specific immune tolerance
#2391Gene therapy vectors and cytosine deaminases
#2392MicroRNAs and uses thereof
#2393Methods and compositions for universal detection of nucleic acids
#2394Compositions for targeted delivery of siRNA
#2395METHOD TO INHIBIT RIBONUCLEASE DICER, RIBONUCLEASE DICER INHIBITOR, AND USE OF RNA APTAMERS AS RIBONUCLEASE DICER INHIBITORS
#2396System For Synergetic Expression Of Multiple Small Functional RNA Elements
#2397miR 204, miR 211, their anti-miRs, and therapeutic uses of same
#2398RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA
#2399COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS
#2400METHOD FOR GENERATION AND REGULATION OF IPS CELLS AND COMPOSITIONS THEREOF